Marshall Wace
CASI

Marshall Wace’s CASI Pharmaceuticals CASI Stock Holding History

Marshall Wace’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-30,051
Closed -$241K – 3398
2021
Q4 		$241K Sell
30,051
-65,153
-68% -$649K ﹤0.01% 3100
2021
Q3 		$1.13M Buy
95,204
+72,833
+326% +$985K ﹤0.01% 1939
2021
Q2 		$347K Buy
+22,371
New +$376K ﹤0.01% 2277
2019
Q4 		– Sell
-3,116
Closed -$104K – 1723
2019
Q3 		$104K Buy
+3,116
New +$100K ﹤0.01% 1393
2019
Q2 		– Sell
-1,525
Closed -$44K – 1390
2019
Q1 		$44K Buy
+1,525
New +$53.1K ﹤0.01% 1549

Other funds holding CASI

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return
WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return